By AstuteAnalytica India Pvt. Ltd.
Publication Date: 2026-02-03 17:53:00
The global market for artificial intelligence (AI) in drug discovery is experiencing rapid growth, driven by the need to reduce the high costs and long timelines of traditional pharmaceutical research and development.
Chicago, Feb. 3, 2026 (GLOBE NEWSWIRE) — The global market for artificial intelligence (AI) in drug discovery is expected to reach $8.10 billion by 2030, growing at a CAGR of 25% during the forecast period 2023-2030, according to recent data from Astute Analytica.
The increasing global burden of chronic diseases – including cancer, diabetes, cardiovascular disease and neurodegenerative diseases – is a powerful catalyst driving the integration of artificial intelligence (AI) into drug discovery. Traditional research and development (R&D) methods often struggle to keep up with the growing demand for effective therapies because these processes are typically time-consuming, costly, and resource-intensive.
Request sample pages:
